arrow
M

Marina Sánchez-Frías

imibic
H指数:11
被引数:525

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma
2025-01-300
OAAI
Quantitative proteomic analysis unveils a critical role of VARS1 in hepatocellular carcinoma aggressiveness through the modulation of MAGI1 expression

定量蛋白质组学分析揭示VARS1通过调节MAGI1表达在肝细胞癌侵袭性中发挥关键作用

2025-01-140
OA
The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma

外显子连接复合物成分EIF4A3在胰腺导管腺癌中发挥剪接相关的致癌作用

2024-09-040
OAAI
Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets
2024-05-242
OAAI
Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response
2024-03-012
OAAI
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach
2023-06-017
OA
Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing
2022-11-2312
OAAI
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug
2021-12-0224
OAAI
Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma

解读CHFR在胰腺导管腺癌中的作用

2021-11-191
OAAI
Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma
2021-01-0158
OAAI
Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease
2019-03-2256
OAAI